Group 1 - The board of directors of Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. held its ninth meeting of the third session on May 28, 2025, with all nine directors present [2][3] - The meeting approved the proposal to amend the company's articles of association and related rules to enhance corporate governance and compliance with relevant laws [2][3] - The board also approved the proposal to revise and establish related systems to further improve the company's governance framework [3][4] Group 2 - The company plans to hold its first extraordinary general meeting of shareholders for 2025 on June 13, 2025, to review matters requiring shareholder approval [4] - All proposals passed with unanimous support, with 9 votes in favor and no votes against or abstaining [3][4]
迈普医学: 第三届董事会第九次会议决议公告